The global vaccine packaging market size was exhibited at USD 1,619 million in 2024 and is projected to hit around USD 2,765 million by 2034, growing at a CAGR of 5.5% during the forecast period 2024 to 2034.
Vaccination initiatives supported by several Governments and rise in major vaccination drives or programs health organizations such as WHO and UNICEF led to an increasing demand for advanced vaccine packaging solutions. These solution compliance with stringent regulatory standards and ensure vaccine safety. The market regulates and maintains the required temperature and ensures the safe shipment of product. The market is experiencing escalating demand from several end-use sectors such as hospitals, clinics, research programs, and other healthcare units.
The growth of the market is majorly driven by the rapid expansion of the pharmaceutical industry is due to increasing prevalence of chronic diseases to provide innovative treatments and therapies to patients. Vaccines plays an integral role to prevent or control the spread of infectious illnesses. Additionally, healthcare expenditure has significantly increased in several developing countries, contributing the overall growth of the vaccine packaging marketing. The rising vaccine R&D by medical institutions along with significant rise in the development from vaccines from various pharmaceutical companies are likely to offer lucrative growth opportunities to the market in the coming years.
Published by Vidyesh Swar
